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Cognitive Function in Fibromyalgia Patients
Denise C. Park, Jennifer M. Glass, Meredith Minear, and Leslie J. Crofford
Objective. To evaluate fibromyalgia (FM) patients
for the presence of cognitive deficits and to test the
hypothesis that abnormalities would fit a model of
cognitive aging.
Methods. We studied 3 groups of patients: FM
patients without concomitant depression and in the
absence of medications known to affect cognitive func-
tion (n 5 23), age- and education-matched controls (n 5
23), and education-matched older controls who were
individually matched to be 20 years older (63 years)
than the FM patients (n 5 22). We measured speed of
information processing, working memory function, free
recall, recognition memory, verbal fluency, and vocabu-
lary. We correlated performance on cognitive tasks with
FM symptoms, including depression, anxiety, pain, and
fatigue. We also determined if memory complaints were
correlated with cognitive performance.
Results. As expected, older controls performed
more poorly than younger controls on speed of process-
ing, working memory, free recall, and verbal fluency.
FM patients performed more poorly than age-matched
controls on all measures, with the exception of process-
ing speed. FM patients performed much like older
controls, except that they showed better speed of pro-
cessing and poorer vocabulary. Impaired cognitive per-
formance in FM patients correlated with pain com-
plaints, but not with depressive or anxiety symptoms.
FM patients reported more memory problems than did
the older and younger controls, and these complaints
correlated with poor cognitive performance.
Conclusion. Cognitive impairment in FM pa-
tients, particularly memory and vocabulary deficits, are
documented in this study. Nevertheless, the intact per-
formance on measures of information processing speed
suggests that the cognitive deficits are not global. FM
patients’ complaints about their memory are likely to
be legitimate, since their memory function is not age
appropriate.
Fibromyalgia (FM) is a disorder of uncertain
etiology characterized by widespread musculoskeletal
pain and the presence of at least 11 of 18 designated
tender points distributed across soft tissues (1). Patients
frequently report diminished cognitive performance, but
few objective data are available on this topic, which is
surprising, given the frequency of, and considerable
disability associated with, cognitive complaints in FM.
Sletvold et al (2) examined a number of cognitive
tasks in FM patients and found evidence of declines in
the speed of processing and working memory. Speed and
working memory are the building blocks of cognitive
function and predict long-term memory (3) and reason-
ing (4). Speed of information processing is measured by
how rapidly an individual can make simple perceptual
decisions, and working memory is measured by how
much information a person can simultaneously store and
process—it is an index of the “mental horsepower” that
an individual brings to any given situation. In a later
study, Landro et al (5) evaluated long-term memory
performance and found that FM patients performed
more poorly on many measures of recall. When only
nondepressed FM patients were examined, the investi-
gators did not find such differences. However, in every
non–statistically significant comparison between the
nondepressed FM patients and the healthy controls, the
FM patients performed worse. Although the study had
limited power, the findings were suggestive of memory
differences in FM patients.
In a recent study, Grace et al (6) found that FM
patients evidenced intact speed of processing, but de-
creased working memory and long-term memory. They
found that self-reported anxiety and pain correlated with
working memory and long-term memory function. Cote
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and Moldofsky (7) also reported that FM patients had
poor cognitive performance on complex cognitive tasks,
and they related the abnormalities to poor stage 1 sleep
quality. However, many of the effects those investigators
found became nonsignificant when education was con-
trolled, so that the deficits they observed are of doubtful
significance. Overall, the limited extant data suggest that
FM patients perform more poorly on a range of cogni-
tive tasks. The studies are limited by small sample size,
poorly matched patients and controls, and, in some cases
(6), failure to eliminate pharmacologic agents that could
have affected cognitive performance.
In the present study, we examined evidence of
cognitive dysfunction in FM patients and addressed the
appropriateness of FM patients’ cognitive complaints.
Grace et al (6) and Pincus et al (8) found that FM
patients reported significantly greater memory problems
than did controls. Finally, because the hypothalamic2
pituitary2adrenal axis function in FM patients is similar
to that in older adults (9), we considered whether FM
patients might also have cognitive function similar to
that of older adults, which might account for their high
rate of memory complaints. It is well documented that
speed of processing, working memory, and long-term
memory decline continuously across the adult lifespan
beginning in the second decade of life (10,11). Thus, to
better understand cognitive function in FM patients, we
included an older control group that consisted of indi-
viduals who were 20 years older than the FM patients
and were matched for education level, as well as a
traditional control group of age- and education-matched
subjects.
PATIENTS AND METHODS
Subjects. We studied 3 different groups of female
subjects: 23 FM patients, 23 healthy age-matched controls, and
22 older adults. The FM patients were recruited from the
Rheumatology Clinic at the University of Michigan and met
the American College of Rheumatology (ACR) classification
criteria for FM. The patients did not have any other rheumatic
diseases or significant health conditions. All patients under-
went structured clinical interviews for diagnosis of disorders
according to the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition; patients with a major depressive
disorder or other major axis I diagnoses were excluded. Prior
to testing, patients discontinued all psychoactive medications
for 2 weeks, with the exception of selective serotonin-reuptake
inhibitors, since these agents do not inhibit cognitive function-
ing (12).
The second group of subjects consisted of 23 female
volunteers recruited from the community and matched indi-
vidually to each FM patient for age and education. The third
group of subjects consisted of 22 women individually matched
to the FM patients for age plus 20 years (63 years) and for
education. None of the control subjects in either age group
were taking psychoactive medication, nor did they have a
current psychiatric diagnosis.
None of the subjects in any group were smokers. All
subjects signed informed consent forms that had been ap-
proved by the University of Michigan Institutional Review
Board. The age and education of the 3 groups of subjects are
displayed in Table 1.
Cognitive testing. Each testing session began at 1:00
PM. Cote and Moldofsky (7) reported that FM patients rated
themselves as having the least fatigue and the least negative
affect during the early afternoon. Thus, we were testing FM
patients at a perceived optimum time of day. The cognitive
testing occurred in 3 blocks, with all 3 blocks administered
successively and completed in a single 2-hour session. Each
block of cognitive tests included measures of 6 domains of
cognitive function: speed of information processing, working
memory capacity, long-term recall, recognition memory, ver-
bal fluency, and vocabulary. Each task had 3 versions, 1 version
in each block. The versions were all highly comparable to one
another.
The 6 cognitive domains and the 3 tasks associated
with each are described below. The presentation order was the
same for all subjects.
Information-processing speed. Speed of information
processing is fundamental to predicting performance on many
higher-order cognitive tasks (10,13). This task is highly age
sensitive and is a measure of how rapidly an individual can
perform mental operations. The 3 tasks used were number
comparison, pattern comparison, and letter comparison. Ad-
ministration was identical for all 3 tasks. Subjects received
sheets of paper with many pairs of digit strings, letter strings, or
angular figures printed on them, depending on the tasks. They
were required to make “same/different” judgments about the
pairs as rapidly as possible. Each test had 3 parts that lasted 30
seconds each. In the first part, subjects made judgments of
strings of 3 numbers or letters, or abstract figures with 3 line
segments. In the second part, there were 6 segments to the
items compared, and 9 segments in the last section. The score
for each speed task is the sum of all correct comparisons
completed on each of the 3 parts.
Working memory capacity. Working memory is a mea-
sure of how much information an individual can simulta-
neously process and store in consciousness. We used 3
computer-based versions of this task—2 versions of reading
span and 1 version of computational span (14). The reading










Age 47.83 47.83 66.91
Education 14.34 14.39 14.50
* All participants were women. Each older control subject was 20 years
older (63 years) than her matched fibromyalgia patient. The fibromy-
algia patients discontinued medications (except for selective serotonin-
reuptake inhibitors) 2 weeks prior to the beginning of the study.
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span tasks involved presenting subjects with factual sentences
and asking them multiple choice questions about the sentence
immediately afterward. At the same time they were to answer
the question about the sentence, they were to also remember
the last word in the sentence. After seeing a certain number of
sentences (between 1 and 6), subjects would be asked to recall
the words from each presented sentence in order. Working
memory span was measured by how many successive items for
which subjects could both answer the question and remember
the final word in the sentence without an error in either.
Computational span is similar, except that subjects solve
simple equations (e.g., 8 1 2) and choose the correct answer
from a multiple choice computer display (e.g., “10”) , but must
also remember the last number in the equation (e.g., “2”).
Subjects received 3 trials at each level of difficulty (e.g., 2
sentences in a row per trial, then 3 sentences in a row per trial).
The total number of correct responses (i.e., correct on both the
questions and recall of the final words) was summed across
trials.
Free recall. Free recall is a measure of long-term
memory and the ability to actively retrieve past episodic
events. A list of items is presented for memorization, and then
recall is tested. In free recall, subjects may recall the items in
any order. Older adults recall fewer items than young adults in
this memory paradigm (3). We tested free recall using 3
different 16-word lists of common nouns. Word lists were
matched for frequency of occurrence in the English language.
For each list, subjects studied 16 words presented one-at-a-
time on the computer screen. Each word appeared for 5
seconds. Subjects were instructed to study the words and try to
remember them. At the end of the list, the word “recall”
appeared on the screen. This prompted subjects to write down
as many words as they could remember, in any order, on their
answer sheets. The score was the number of words correctly
recalled.
Recognition memory. Recognition memory is a mea-
sure of a subject’s ability to recognize a previously studied
item. Because no active retrieval from memory is required, age
differences tend to be small here, and we expected that the FM
patients might perform as well as the age-matched controls on
this task. For this task, subjects studied 32 words. Then they
were presented with 32 more items—half from the studied list
and half that were new. The subject’s task was to identify each
item as “old” (studied earlier) or “new” (never studied). There
were 3 tests, 1 in each block; word frequency in the language
was equated across the 3 lists. The dependent measure was d9,
an estimate of how effectively subjects can discriminate old
from new items. A d9 of zero indicates that a subject was
unable to discriminate the old from the new items and
essentially had no memory for them.
Verbal fluency. This task relies on the ability of the
subject to quickly and efficiently retrieve information from
their existing knowledge stores. It is age sensitive, in that it
requires active retrieval or mental effort, and we expected that
FM patients might have difficulty with this task. We used the
F-A-S verbal fluency test (15). On each block of testing,
subjects were given a sheet of paper with the letter F, A, or S
on top. They were given 90 seconds to write down as many
words as they could that began with the letter that was written
on the page. The dependent measure was the number of words
produced, excluding repeated words.
Verbal knowledge.We used 3 vocabulary tests to assess
verbal knowledge. This task, like verbal fluency, relies on
knowledge. It is different from verbal fluency in that it does not
require active retrieval. Subjects were given a series of words in
a multiple choice format. In the Antonym Task (14), they were
to select the antonym of each word, in another test, the
synonym of the word, and in the Shipley Institute of Living
Vocabulary Test (16), they were to select a synonym of the
word.
Assessment of depression, anxiety, pain, fatigue, and
memory complaints. Ratings instruments, along with a
demographic/health questionnaire, were completed before the
cognitive testing. Depressive symptoms were measured with 2
questionnaires, the Beck Depression Inventory (BDI) (17) and
the Geriatric Depression Scale (GDS) (18). The BDI has
typically been used in FM research; the GDS was also used
because it has less focus on somatic symptoms and might
therefore be a more accurate assessment of depressive symp-
toms in FM patients independently of their health complaints.
Anxiety was measured with the Anxiety subscale of the
Mental Health Inventory (19). Pain was measured with the
McGill Pain Questionnaire (MPQ) (20) and with the Pain
subscale of the Arthritis Impact Measurement Scales (AIMS)
(21). Fatigue was measured with a questionnaire that we
patterned after the AIMS Pain subscale; it measured the
impact of fatigue on daily activities. Beliefs about memory
function were measured with the Pincus Cognitive Symptoms
Inventory (8). This inventory focuses on everyday cognitive
tasks, such as remembering shopping items without a list,
dialing a telephone number, or remembering the location of
common items such as keys.
Study design and analysis. To test our hypotheses
about differences in cognitive performance between the 3
groups, we first used a between-groups experimental design.
Multivariate analysis of variance (MANOVA) was used to
assess the overall between-group effects across the 6 cognitive
domains. With a significant overall multivariate effect, planned
univariate comparisons were completed to assess group differ-
ences for individual cognitive domains.
RESULTS
Cognitive measures. Although we expected inter-
esting interactions of patient groups over time (e.g.,
effects of fatigue), preliminary analyses indicated that no
main effects or interactions emerged as a function of the
testing block on any tasks. That is to say, the perfor-
mance of subjects in all groups was unchanged on each
test across the 3 testing blocks. Thus, we report aggre-
gate performance on the 3 tests and will not report
analyses across the blocking measure.
A MANOVA was conducted on the 6 cognitive
measures, with group as the independent variable. The
MANOVA yielded a significant group effect (Pillai’s
trace[12,124] 5 2.465, P 5 0.006). To further assess
these group effects, planned univariate analyses (1-tailed
paired t-tests except where noted otherwise) for individ-
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ual cognitive tests are described below. The means and
standard deviations for each cognitive domain are shown
in Table 2.
Age-matched controls compared with older con-
trols. We first established that we observed typical
patterns of cognitive aging in the older versus the
younger control groups. Older adults typically have
poorer performance on measures that require intensive
processing or active retrieval, and show small effects or
no effects on recognition memory. In contrast, age
differences in world knowledge are either absent or in
favor of older adults (10). We observed this pattern of
effects in the present sample, despite only a 20-year
difference between older and younger subjects. The
older subjects performed more poorly than the younger,
age-matched control group on measures of information-
processing speed (t[21] 5 2.5, P 5 0.011), working
memory capacity (t[21] 5 1.929, P 5 0.034), free recall
(t[21] 5 2.687, P 5 0.007), and verbal fluency (t[21] 5
1.937, P 5 0.033). There were no differences between
these groups on measures of recognition memory (t[21]
5 0.615, P 5 0.545) and verbal knowledge (t[21] 5
0.674, P 5 0.508).
FM patients compared with age-matched controls.
Next, we examined the performance of FM patients
compared with age-matched controls. We noted cogni-
tive differences in a number of domains. The FM
patients performed more poorly than the age-matched
control group on measures of working memory capacity
(t[22] 5 1.811, P 5 0.042), free recall (t[22] 5 2.881, P 5
0.005), recognition memory (t[22] 5 1.915, P 5 0.035),
and verbal knowledge (t[22] 5 4.06, P , 0.001). Perfor-
mance on verbal fluency was marginally worse in the FM
patients compared with the age-matched controls (t[22]
5 1.667, P 5 0.055). There was no difference in perfor-
mance for the information-processing speed (t[22] 5
0.031, P 5 0.975).
FM patients compared with older controls. The
performance of the FM patients was similar to that of
the older controls on measures of working memory
(t[21] 5 0.103, P 5 0.909), free recall (t[21] 5 0.549, P 5
0.588), recognition memory (t[21] 5 1.394, P 5 0.177),
and verbal fluency (t[21] 5 0.14, P 5 0.89). However,
there were 2 important areas where FM patients per-
formed differently from older controls. First, the FM
patients were significantly faster on measures of
information-processing speed (t[21] 5 2.721, P 5 0.013,
2-tailed) compared with older controls, suggesting that
basic information-processing speed was intact. In con-
trast to this, FM patients performed more poorly than
older controls on measures of verbal knowledge (t[21] 5
2.886, P 5 0.009, 2-tailed).
Psychological measures. A MANOVA was con-
ducted on the psychological measures, with group as an
independent variable. The psychological measures in-
cluded 6 measures: 2 of depression, 2 of pain, 1 of
anxiety, and 1 of fatigue. The means for these variables
as a function of group are shown in Table 3. The
MANOVA yielded a significant group effect (Pillai’s
trace[12,120] 5 6.323, P , 0.001). To further assess
these group effects, planned univariate analyses (one-
way ANOVA) for individual psychological measures are
described below. It should be noted that the cutoff
scores for mild depression for the BDI and GDS are 19
and 15, respectively. Thus, due to initial screening, no
group in the study had a mean score that was indicative
of even mild depression.
Age-matched controls compared with older con-
trols. In general, older controls reported somewhat more
depression, fatigue, and pain than the younger controls.
The older control subjects reported more depressive
symptoms than the age-matched control group on the
BDI (F[1,42] 5 7.845, P 5 0.008). The difference
between these groups on the GDS did not reach signif-
icance (F[1,42] 5 2.906, P 5 0.096). There was no
significant difference in anxiety for older controls and
age-matched controls (F[1,44] 5 0.002). Older controls
reported more fatigue (F[1,44] 5 4.416, P 5 0.041).










Information-processing speed 139.45 6 29.55 139.23 6 29.55 118.50 6 19.15
Working memory 22.22 6 7.85 26.30 6 1.67 22.09 6 6.27
Free recall 23.56 6 7.80 27.83 6 6.43 23.91 6 6.77
Recognition memory 2.53 6 1.19 2.95 6 1.07 2.80 6 1.19
Verbal fluency 49.78 6 11.63 56.08 6 15.65 49.43 6 13.74
Verbal knowledge 43.17 6 7.62 51.26 6 6.01 50.56 6 7.93
* Values are the mean 6 SD.
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Older controls also reported more pain on the AIMS
Pain subscale (F[1,44] 5 9.516, P 5 0.004), but the
difference on the MPQ did not reach significance
(F[1,44] 5 3.322, P 5 0.075).
FM patients compared with age-matched controls.
The FM patients reported more depressive symptoms on
the BDI (F[1,44] 5 21.183, P , 0.0001) and on the GDS
(F[1,44] 5 28.75, P , 0.0001). The FM patients reported
more anxiety (F[1,45] 5 12.538, P 5 0.001) and more
fatigue (F[1,45] 5 102.815, P , 0.0001). The FM
patients also reported more pain on the MPQ (F[1,45] 5
102.423, P , 0.0001) and on the AIMS Pain subscale
(F[1,45] 5 160.145, P , 0.0001).
FM patients compared with older controls. The FM
patients reported more depressive symptoms than the
older controls on the BDI (F[1,44] 5 8.231, P 5 0.006)
and on the GDS (F[1,44] 5 12.881, P 5 0.001). The FM
patients reported more anxiety (F[1,45] 5 9.959, P 5
0.003) and more fatigue (F[1,45] 5 55.556, P , 0.0001).
The FM patients also reported more pain on the MPQ
(F[1,45] 5 30.753, P , 0.0001) and on the AIMS Pain
subscale (F[1,45] 5 59.085, P , 0.0001).
Memory complaints. A one-way ANOVA was
conducted on the scores on the Pincus Cognitive Symp-
toms Inventory, with group as the independent variable.
Older controls reported more cognitive problems than
the age-matched controls (F[1,44] 5 3.989, P 5 0.052).
FM patients also reported more cognitive problems than
either the age-matched controls (F[1,45] 5 38.99, P ,
0.0001) or the older controls (F[1,45] 5 25.447, P ,
0.0001).
Relationship of psychological variables to cognitive
performance in FM patients. To assess the relationship of
the psychological measures to cognitive performance
and to cognitive complaints, we correlated the 6 psycho-
logical measures with the 6 cognitive variables and with
the memory complaint measure for FM patients. These
correlations allowed us to determine if patients who
scored high on depression, anxiety, pain, or fatigue
performed more poorly on cognitive measures or had
higher numbers of memory complaints. Of particular
interest was whether depression or anxiety had a signif-
icant relationship to cognitive function, since this has
been suggested in previous research.
We did not find any significant correlations be-
tween the anxiety, the BDI, or the GDS and the
cognitive measures. In contrast, the AIMS Pain subscale
correlated highly with 4 cognitive measures:
information-processing speed (r 5 20.662, P 5 0.001),
working memory capacity (r 5 20.466, P 5 0.022), free
recall (r 5 20.607, P 5 0.002), and recognition memory
(r 5 20.555, P 5 0.005). The MPQ correlated only with
free recall (r 5 20.441, P 5 0.031). The difference in
correlations between the 2 pain measures may be due to
the focus of the AIMS on the functional impact of pain,
rather than on the level of pain itself. There were no
other significant correlations among the psychological
and cognitive measures.
We also found that cognitive complaints were
correlated with poor cognitive function in FM patients.
When a measure of the total number of cognitive
problems experienced most or all of the time was
correlated with the 6 cognitive performance measures,
there were significant correlations for information-
processing speed (r 5 20.507, P 5 0.005), working
memory capacity (r 5 20.406, P 5 0.049), and free
recall (r 5 20.448, P 5 0.028).
DISCUSSION
The major findings from this study are as follows.
First, FM patients performed more poorly on most
cognitive measures compared with age- and education-
matched controls, although they did evidence intact
speed of information processing. Second, FM patients
performed no differently from healthy adults 20 years










Beck Depression Inventory 15.21 6 10.92 4.05 6 3.30 7.82 6 5.39
Geriatric Depression Scale 11.96 6 6.40 3.77 6 3.34 5.91 6 4.84
Anxiety† 36.17 6 9.48 44.26 6 5.62 44.17 6 7.79
Fatigue 29.29 6 5.55 13.70 6 4.97 17.02 6 5.74
McGill Pain Questionnaire 33.75 6 9.15 9.57 6 7.05 15.30 6 13.35
AIMS Pain subscale 30.17 6 6.64 9.98 6 3.88 15.04 6 6.85
* Values are the mean 6 SD. AIMS 5 Arthritis Impact Measurement Scales.
† Higher scores indicate less anxiety.
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older than their chronological age on most cognitive
tasks, except that FM patients had a faster rate of
information processing and poorer verbal knowledge
than older adults. Third, within the FM group, only
self-reported pain on the AIMS predicted poor cognitive
performance. Measures of depression, anxiety, and the
MPQ scores were all unrelated to poor cognitive perfor-
mance in FM patients. Finally, cognitive complaints in
FM patients were significantly correlated with poorer
memory performance.
Cognitive performance of FM patients relative to
age-matched controls. The finding that FM patients
performed more poorly on measures of working mem-
ory function, free recall, verbal fluency, and verbal
knowledge, but showed intact speed of processing rela-
tive to age-matched controls confirms the report by
Grace et al (6), who found an almost identical pattern.
Those investigators reported that although FM patients
processed information as rapidly as age-matched con-
trols, they had poorer working memory and long-term
memory function. They matched their FM patients for
reading ability, rather than for age and education as we
did in the present study, and they did not collect
measures of verbal knowledge.
We were surprised by the FM patients’ poor
performance on verbal knowledge tasks and considered
the possibility that the poorer performance relative to
age-matched controls could be due to imprecise subject
matching for years of education or age, with FM having
lower education or being older than their controls.
However, as shown in Table 4, control subject matching
was impeccable with respect to both age and education
and cannot account for the differences observed. We
believe that decreased access to word knowledge is a
feature of cognitive dysfunction in FM, particularly since
these findings confirm the frequently reported symptom
by FM patients of decreased availability of word mean-
ing. Thus, although further study is merited, the finding
of decreased access to verbal knowledge appears reliable
in the present study.
The fact that speed of processing was intact in
FM patients suggests that the most basic and global
information-processing ability—how fast we process
new information—is not a problem for FM patients. Our
findings do indicate that FM patients have more limited
working memory and long-term memory than do age-
matched controls. The cognitive symptoms described by
these patients are likely to be related to difficulties in
these domains.
One other important point with respect to the
Table 4. Subject-by-subject matching for education and age (or age plus 20 years)



















55 53 75 13 13 13
53 53 75 17 17 17
56 54 78 13 13 13
48 49 69 16 16 16
42 44 62 12 13 12
29 27 50 16 16 16
57 56 76 12 13 13
47 49 66 17 17 17
59 61 79 13 12 13
46 44 64 18 17 17
52 50 70 13 13 13
51 53 69 16 16 16
46 45 64 16 16 16
49 47 69 17 17 17
37 36 54 13 13 13
58 62 – 11 12 –
45 45 64 12 12 12
46 45 64 17 17 17
31 30 55 16 16 16
39 41 59 13 13 13
54 52 74 13 13 13
46 46 66 13 13 13
54 58 73 13 13 13
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FM patients is that they did not show any evidence of
fatigue across testing blocks. We had hypothesized that
the performance of the FM patients would deteriorate
steadily over time, and we had 3 versions of each
cognitive test performed at 3 different times within the
2-hour session. No subject group showed fatigue effects
or evidence that their performance improved or de-
creased across these 3 test intervals. Thus, in addition to
confirming evidence of cognitive dysfunction in FM
patients, this study also found that the dysfunction is not
exacerbated over a 2-hour period of intensive cognitive
performance.
Similarities of FM to cognitive aging. If one
excludes performance on information-processing speed
and a recognition memory task that is relatively low in
cognitive demands, FM patients performed much like
adults 20 years older on measures of working memory
and long-term memory. From a practical standpoint, this
suggests that FM patients have as much trouble as older
adults in harnessing working memory to perform cogni-
tive tasks and, moreover, that they have more trouble
remembering information once it is processed in their
working memory. As noted above, however, cognitive
aging is an imperfect model for FM, since FM patients
differed from older adults in that they had intact
information-processing speed.
Speed of processing is fundamental to nearly all
cognitive abilities and is viewed as a global indicator of
neurobiologic deterioration in elderly adults (22). Speed
decreases that occur with age have been hypothesized to
be related to age-related declines in dopamine recep-
tors, decreased brain weight, increased dendritic branch-
ing that leads to circuitous cognitive processing, or
decreases in myelin sheath (23,24). The failure to find a
speed deficit in both this study and the study by Grace et
al (6) is certainly good news for FM patients and sug-
gests that the cognitive dysfunction associated with FM
cannot be viewed simply as accelerated cognitive aging.
The processes that did decline in FM patients
similarly to elderly adults, working memory function and
encoding and retrieving words (the long-term memory
task), have known neurobiologic substrates. Working
memory and encoding and retrieval operations are
functions that reside primarily in the dorsolateral pre-
frontal cortex (25,26). Moreover, there is evidence from
the neuroimaging literature that older adults show com-
pensatory hemispheric recruitment on working memory
tasks. For example, younger adults use primarily the left
frontal cortex when performing a verbal working mem-
ory task, whereas older adults show evidence of activa-
tion in both the left and right hemispheres when per-
forming the same task (27). Similar compensatory
patterns have been observed for the encoding and retrieval
of words in long-term memory in older adults (28).
Some of the debate regarding the neurobiologic
basis for observed FM memory dysfunction could be
resolved by determining whether FM patients show
recruitment patterns in the frontal cortex typical of
young or older adults. Evidence that FM patients re-
cruited cortical tissue in the same way as older adults or
showed compensation in other cortical areas (such as the
parietal or visual cortex) compared with controls would
be strong evidence for an underlying neurobiologic
alteration in information processing in FM patients. In
short, there is both compelling behavioral evidence as
well as available noninvasive technology that should
allow us to resolve the neurobiologic underpinnings of
poor cognitive performance in FM patients (29,30).
Psychological correlates of poor cognitive perfor-
mance. We found no evidence that anxiety or depression
was correlated with poor cognitive performance in FM
patients. On the one hand, this is not surprising, because
patients were carefully screened for depression, and
mean symptom scores were below those for mild depres-
sion. On the other hand, depression is frequently cited as
a cause of poor cognitive performance in FM patients,
and the FM patients in this study scored higher than
controls for symptoms of depression. One of the hall-
marks of depressed individuals, however, is slowed psy-
chomotor performance (31), and the FM patients had
intact speed of processing. The pattern of intact speed of
processing but decreased function in working memory
and long-term memory observed in FM patients is not a
pattern that would be typical of depressed or poorly
motivated adults.
The symptom that did correlate with poor cogni-
tive performance in FM patients was self reports of pain
on the AIMS Pain subscale (21) but not the MPQ (20).
The AIMS primarily measures everyday dysfunction due
to pain and the MPQ measures pain intensity in a more
focused manner. Given that the cognitive measures
showed the stronger relationship to pain-related dys-
function in everyday life, it suggests that memory dys-
function and activity-limiting pain are concomitants in
FM. That is, it may be that chronic pain and cognitive
dysfunction co-occur with FM. An alternative explana-
tion is that the cognitive deficits observed in FM patients
are due to their attention being diverted to coping with
pain while performing the cognitive tasks, so that they
have decreased cognitive resource available for perform-
ing the working memory and long-term memory tasks.
However, this argument would suggest that the MPQ
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would show the higher correlations with cognitive func-
tion, since it is a better measure of pain at the time of
test-taking. In any case, this issue is an interesting and
important one and can be addressed in future studies in
which FM patients are tested with matched pain con-
trols. Grace et al (6) also concluded that the possibility
of pain interfering with cognition was interesting and
worthy of further research.
Cognitive complaints and cognitive performance.
There are 4 lines of evidence that suggest that the
complaints of FM patients about their memory are
legitimate. First, FM patients performed more poorly
than aged-matched controls on a range of cognitive
tasks, which suggests a legitimate basis for complaints
about their memory. Second, FM patients performed
much like older adults on many cognitive tasks, although
the patients complained more about their memory than
the older adults who performed similarly. However, the
older adults’ performance was normative for their age
group, whereas the FM patients’ performance was not
normative for their age. Thus, the greater complaints
about memory in younger FM patients compared with
older adults who are performing similarly appear war-
ranted. Third, in older adults, there is little relationship
between memory complaints and memory performance
(for review, see ref. 32). We were very surprised to see
that in FM patients, there was a significant correlation
between their memory complaints and their actual mem-
ory performance. This is very convincing evidence that
FM patients’ complaints about their memory are legiti-
mate. Finally, given that there was no relationship
between cognitive function and either depression, anxi-
ety, or fatigue, but there was a relationship between
cognitive function and memory complaints, there is little
validity to the notion that psychological distress is the
basis for memory dysfunction or complaints about mem-
ory in FM patients.
Conclusions and future directions. The present
pattern of findings demonstrates that FM patients have
cognitive function that is poorer than that in age-
matched controls and similar to that in adults 20 years
older with respect to working memory and long-term
memory. An important difference between FM patients
and older control subjects, however, is an intact speed of
processing. This suggests that the etiology of their
memory dysfunction is different from that in older
adults, since the cognitive decline in older adults is
mediated by deficits in the speed of processing. We view
the intact speed of processing as a hopeful sign that FM
memory deficits can be remedied. The correlation ana-
lyses suggest that the poor memory function is related to
pain, although we cannot assign a causal role based on
these studies. The FM patients have more memory
complaints than do young or old controls, but these
complaints correlate with cognitive performance.
The present study documents that complaints of
memory dysfunction in FM patients are accompanied
by true cognitive dysfunction. In this study, depression
did not explain cognitive impairment. Rather, pain or
other neurobiologic perturbations may account for the
findings.
The present study was not designed to address
the etiology of FM. However, we are working from a
model that suggests that FM is a neurobiologic disorder
that occurs in response to a physical or environmental
stressor (e.g., a viral illness, a car accident, emotional
trauma) that disrupts hypothalamic2pituitary2adrenal
axis function (9), resulting in a cascade of disabling
symptoms, including pain and measurable cognitive dys-
function. Much more research needs to be done on this
puzzling disorder to understand the neurobiologic sub-
strates of associated dysfunction and to determine the
reversibility of the dysfunction as well as treatment
mechanisms for the symptoms. Understanding such con-
nections should lead to more effective treatment.
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